Instead of giving estrogen treatment, our study used the newly developed brain-specific aromatase transgenic mice, Thy1-Ar, reported that elevation of brain estrogen level can reduce depression-like behavior in both sexes. Here, CYP19A1 is linked to depressive symptom measurement.